You are here: Industry Insights > AI

News List

Pharma Sources Insight January 2024: Pharmaceutical Industry in 2024 - Flexible Production, Innovative Drugs and Personalized Medicine Pharma Sources Insight
January 15, 2024
Pharmaceutical Industry Outlook in 2024.
What To Expect in the 2024 Pharmaceutical Market Suzanne Elvidge
January 12, 2024
The pharmaceutical market is growing fast. According to Statista.The largest market is oncology, predicted to be worth US$214.10 billion in 2024.
Advancements in scientific technologies to Drug discovery and Development 2023 Shruti Talashi
January 02, 2024
Technological advancement apart from a deeper comprehension of disease biology, and an emphasis on breaking down conventional boundaries is driving this era of profound change in the drug development industry.
MNC ramps up AI pharmaceutical layout, can AI and pharmaceuticals collide to spark "fireworks"? Yefenghong/PharmaSources
October 27, 2023
AI (Artificial Intelligence) pharmaceuticals refer to the use of artificial intelligence technologies such as big data, cloud computing, and deep learning to assist in drug discovery, drug management, efficacy analysis, and other processes.
Traditional drug manufacturing is evolving into Bio-foundry : A long way to go! Shruti Talashi
August 08, 2023
Pharmaceutical industries are changing their approach to drug discovery, the new in trend is bio-manufacturing based on bio-foundry model approach.
AI powers drug R&D OpenAI technology promises a new technological revolution PharmaSources
April 27, 2023
With the development of technology, AI technology has been widely used in several medical field scenarios.
Pharma Sources Insight April 2023: Innovative Drugs Going Abroad Pharma Sources Insight
April 18, 2023
A look into the innovative drugs R&D and emerging market.
4D Lifetec Secures CHF 23.3 Mio in a Share and Investment Deal with Xlife Sciences Opening New Horizons in Using AI and Digital Health in Early Cancer Detection B3C newswire
November 06, 2023
In a significant financial milestone, Xlife Sciences AG invests CHF 23.3 million in 4D Lifetec AG, acquiring a 20% stake in the company.
Merck KGaA, Quris Partner on BioAI Platform for Clinical Safety Prediction contractpharma
February 10, 2022
Merck KGaA to assess Quris’s BioAI safety prediction platform, comparing it to traditional in vitro and in vivo approaches.
Colorcon Ventures Invests in Bio-Simulation Startup VeriSIM Life contractpharma
January 18, 2022
VeriSIM’s platform accelerates drug development and reduces animal testing.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 18 19 Next page